IsuueWire: Code Pharma Announces a Limited Fundraising Round
According to IssueWire, “Code Pharma plans to launch an Initial Public Offering (IPO) on the NASDAQ and Switzerland’s SIX Swiss Exchange. The company had launched a limited fundraising round for international expert investors, allowing them to acquire its shares at a 20% discount with a minimum of USD 100,000 starting from November 25, 2021. All […]
IsuueWire: Code Pharma Announces a Limited Fundraising Round Read More »
